AWARDPURCHASE ORDERSmall business
Purchase order W81K0021P0207AUSTIN NUCLEAR PHARMACY SERVICES LLC
Overview
Award facts
- Net obligations
- $343.3K
- $343,300of $373.37K potential value
- Outlays (paid to date)
- $65.59K
- $65.59K paid of $343.3K obligated$65,587
- Period of performance
- Oct 1, 2021 to Sep 30, 2025
- Ended
- Modifications
- 20
- Latest action May 5, 2025
- Contract type
- Purchase order
- PIID W81K0021P0207
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
RADIOPHARMACEUTICALS
Dates and value
- Award date
- Signed on Jul 29, 2021
- Potential end of performance
- Sep 29, 2025
- Current value
- $373,371Base and exercised options
- Potential value (if all options are exercised)
- $373,371
Obligations by fiscal year of action
- FY2025: $83,008
- FY2024: $8,158
- FY2023: $74,963
- FY2022: $177,172
Total across 4 fiscal years: $343,300
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 20, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 5, 2025. View on USAspending
Recipient
NameAUSTIN NUCLEAR PHARMACY SERVICES LLC
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Defense
- Department Of The Army
- W40M MRC0 WEST
- Funded by
- Department of Defense
- Defense Health Agency
- AMC HOOD - PA
- Funded from
- Operation and maintenance; UndistributedProgram activities097-0130Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Temple, Texas
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Competed under SAPF
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 3
Solicitation and notices
- Solicitation ID
- W81K0021Q0103
- Notices
- Solicitation posted Jul 12, 2021
- Solicitation posted Jun 8, 2021
- Presolicitation posted May 26, 2021
Contract details
- Subcontracting plan
- Plan not requiredB
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jul 29, 2021
- Latest action
- May 5, 2025 — Funding onlyModification P00020; obligation change -$158,310; funding only: changes obligations, not scope
- Latest substantive action
- Dec 6, 2023 — Option exercisedModification P00015
- Latest funding action
- May 5, 2025 — Funding onlyModification P00020; obligation change -$158,310; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Funding only12
- Other administrative action4
- Option exercised3
- Supplemental agreement (within scope)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$158,310
- Latest action: change in base and all options
- -$158,310
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Meets requirementsA
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
- Sea transportation
- UnknownU
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- IT commercial item category
- Not IT products or servicesZ
- DoD claimant program
- Medical and dental supplies and equipmentC9B
- Awarding agency code
- 9700
- Awarding sub-tier code
- 2100
- Contracting office code
- W81K00
- Transactions recorded under this award key
- 21
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 97DH
- Funding office code
- HT0858
- Treasury accounts
- 097-2022/2022-0130-000
- 097-2023/2023-0130-000
- 097-2024/2024-0130-000
- 097-2025/2025-0130-000
- Object classes
- 26.0: Supplies and materials
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression